This document is page 122 of a December 2017 Cannabis Investment Report by Ackrell Capital. It provides a financial summary and stock price performance analysis of U.S. publicly traded cannabis-related companies as of November 2017. The report notes that the election of Donald Trump and the confirmation of Jeff Sessions did not negatively impact the stock performance of these companies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production to Congress.
| Name | Role | Context |
|---|---|---|
| Donald Trump | U.S. President |
Mentioned in the context of his election not slowing the performance of cannabis stocks.
|
| Jeff Sessions | U.S. Attorney General |
Mentioned in the context of his confirmation not slowing the performance of cannabis stocks.
|
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC |
Investment firm issuing the Cannabis Investment Report.
|
|
| S&P Global Market Intelligence |
Cited as the source for market data.
|
|
| Nasdaq |
Listed as a market for cannabis companies.
|
|
| NYSE |
Listed as a market for cannabis companies.
|
|
| NYSE American |
Listed as a market for cannabis companies.
|
|
| FINRA |
Ackrell Capital is listed as a member.
|
|
| SIPC |
Ackrell Capital is listed as a member.
|
|
| House Oversight Committee |
Implied by the Bates stamp 'HOUSE_OVERSIGHT'.
|
| Location | Context |
|---|---|
|
Focus of the market analysis.
|
"As shown in this chart, the election of Donald Trump as President and the selection of Jeff Sessions as Attorney General of the United States have not slowed the continuing positive price performance of cannabis-related companies trading on U.S. markets."Source
Complete text extracted from the document (1,911 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document